Share

July 30, 2013; 81 (5) Special Article

Evidence-based guideline: Treatment of tardive syndromes

Report of the Guideline Development Subcommittee of the American Academy of Neurology

Roongroj Bhidayasiri, Stanley Fahn, William J. Weiner, Gary S. Gronseth, Kelly L. Sullivan, Theresa A. Zesiewicz
First published July 29, 2013, DOI: https://doi.org/10.1212/WNL.0b013e31829d86b6
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
13995

Share

This article has a correction. Please see:

Article Information

vol. 81 no. 5 463-469
DOI: 
https://doi.org/10.1212/WNL.0b013e31829d86b6
PubMed: 
23897874
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received October 5, 2012
  • Accepted in final form April 22, 2013
  • First Published July 29, 2013.
Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Roongroj Bhidayasiri, MD, FRCP,
    2. Stanley Fahn, MD, FAAN,
    3. William J. Weiner, MD, FAAN†,
    4. Gary S. Gronseth, MD, FAAN,
    5. Kelly L. Sullivan, PhD and
    6. Theresa A. Zesiewicz, MD, FAAN
  1. Roongroj Bhidayasiri, MD, FRCP,
    2. Scientific Advisory Boards:

    1. 1) Scientific advisory board, Ministry of Public Health, Thailand 2) Ipsen pharmaceuticals

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Abbott, BL Hua, Boehringer-Ingelheim, GlaxoSmithKline, Medtronic, Novartis, Roche pharmaceuticals

    Editorial Boards:

    1. Thai Journal of Neurology: Editor-in-chief (2010-2012)

    Patents:

    1. 1) Laser cane for Parkinson disease 2) Electronic Parkinson Disease Diary software for PDA

    Publishing Royalties:

    1. 1) Neurological differential diagnosis, Wiley-Blackwell, 2005 2) International Neurology, Wiley-Blackwell, 2009 3) Movement Disorders: A video atlas, Humana Press, 2012

    Employment, Commercial Entity:

    1. 1) Chulalongkorn University, Associate Professor of Neurology 2) UCLA School of Medicine, Visiting Associate Professor of Neurology

    Consultancies:

    1. Ipsen pharmaceuticals

    Speakers' Bureaus:

    1. Abbott, BL Hua, Boehringer-Ingelheim, GlaxoSmithKline, Medtronic, Novartis, Roche pharmaceuticals

    Other activities:

    1. Director of Chulalongkorn Center of Excellence on Parkinson's Disease & Related Disorders, Thai Red Cross society

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. 1) Duodopa, Abbott pharmaceuticals 2) HMS 90 Whey protein isolate, Immunocal Thailand

    Research Support, Government Entities:

    1. 1) Thailand Research Fund: 2008-2009

    Research Support, Academic Entities:

    1. 1) Rachadaphiseksomphot Endowment Fund part of the “Strengthen CU's Researcher's Project, Chulalongkorn University, Bangkok, Thailand. 2) Research unit grant number GRU 52-026- 30-005 of Chulalongkorn University, Bangkok, Thailand.

    Research Support, Foundations and Societies:

    1. 1) Thai Red Cross society, Parkinson Disease Center Development Grant

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Stanley Fahn, MD, FAAN,
    3. Scientific Advisory Boards:

    1. Commercial - Merz Pharma

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Commercial - Sun Pharmaceuticals India for travel and honoraria to speak at a course for neurologists in India

    Editorial Boards:

    1. Springer Publishers for serving as co-editor of Current Neurology and Neurosurgery Report

    Patents:

    1. NONE

    Publishing Royalties:

    1. Elsevier Publishers for co-authorship of book "Principles and Practice of Movement Disorders"

    Employment, Commercial Entity:

    1. Columbia University

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Parkinson's Disease Foundation Smart Family Foundation (Dec. 2012).

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. William J. Weiner, MD, FAAN†,
    4. Scientific Advisory Boards:

    1. Served on the scientific advisory boards for (1) Santhera; (2) Rexahn

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. (1) Current Treatment Options in Neurology - Editor; (2) Parkinsonism and Related Disorders - Editorial Board (3) Journal of Neurological Reviews

    Patents:

    1. NONE

    Publishing Royalties:

    1. Royalties from Lippicott Williams Wilkins, Elsevier, Hopkins

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Gary S. Gronseth, MD, FAAN,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Neurology Now

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. Boehringer Ingelheim 2007-2011(Resigned Dec 2011)

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. American Academy of Neurology

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Kelly L. Sullivan, PhD and
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Theresa A. Zesiewicz, MD, FAAN
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) TEVA- speaking engagements (2) UCB Speakers Bureau (3) GE Healthcare Speaker Program

    Editorial Boards:

    1. Tremor and Other Hyperkinetic Movement Disorders, Editorial Board 2011

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. (1) TEVA- speaking engagements (2) UCB Speakers Bureau (3) GE Healthcare Speaker Program

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. (1) TEVA (2) UCB (3) GE Healthcare

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) GlaxoSmithKline (2) UCB Pharmaceuticals (3) Edison Pharmaceuticals (4) Boehringer-Ingelheim (5) Novartis (6) Teva Neuroscience (7) Pfizer (8) Allergan.

    Research Support, Government Entities:

    1. (1) UCLA-RAND

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) National Ataxia Foundation, grant support (2) Friedreich's Ataxia Research Association, grant support (3) Bobby Allison Ataxia Research Center, grant support

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Chulalongkorn Parkinson's Disease and Related Disorders Center of Excellence, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society (R.B.), Bangkok, Thailand; Department of Neurology (R.B.), David Geffen School of Medicine at UCLA, Los Angeles, CA; Department of Neurology (S.F.), Columbia University, New York, NY; Department of Neurology (W.J.W.), University of Maryland, Baltimore, MD; Department of Neurology (G.S.G.), University of Kansas Medical Center, Kansas City, KS; and Department of Neurology (K.L.S., T.A.Z.), University of South Florida, Tampa, FL.
  1. Correspondence to American Academy of Neurology: guidelines{at}aan.com
View Full Text

Article usage

Article usage: July 2013 to December 2021

AbstractFullPdfSource
Jul 20131875154470Highwire
Aug 20132606501774Highwire
Sep 2013725257419Highwire
Oct 2013565296308Highwire
Nov 2013482198233Highwire
Dec 2013366163192Highwire
Jan 2014427181241Highwire
Feb 2014379197219Highwire
Mar 2014426217235Highwire
Apr 2014413199191Highwire
May 2014225115168Highwire
Jun 2014269133144Highwire
Jul 2014213124144Highwire
Aug 2014226116147Highwire
Sep 2014241143159Highwire
Oct 2014242123170Highwire
Nov 2014186121167Highwire
Dec 201422096111Highwire
Jan 20152487995Highwire
Feb 2015239112114Highwire
Mar 2015285126146Highwire
Apr 201526798133Highwire
May 201528288161Highwire
Jun 201523383152Highwire
Jul 2015269113140Highwire
Aug 201528793135Highwire
Sep 2015245127122Highwire
Oct 2015237117144Highwire
Nov 201526497127Highwire
Dec 201524383113Highwire
Jan 20161956196Highwire
Feb 201617492121Highwire
Mar 2016149113116Highwire
Apr 2016127144102Highwire
May 2016165107105Highwire
Jun 2016966665Highwire
Jul 20161147497Highwire
Aug 201613894118Highwire
Sep 201614210199Highwire
Oct 201613413892Highwire
Nov 2016151151144Highwire
Dec 2016955469Highwire
Jan 2017139110109Highwire
Feb 20171168883Highwire
Mar 201715891107Highwire
Apr 2017159120144Highwire
May 2017164161128Highwire
Jun 2017177172184Highwire
Jul 2017126107188Highwire
Aug 2017109173160Highwire
Sep 201767182164Highwire
Oct 201784187172Highwire
Nov 201770188179Highwire
Dec 20171722387Highwire
Jan 20188368110Highwire
Feb 201812329125Highwire
Mar 201816410113Highwire
Apr 201816303105Highwire
May 20181831393Highwire
Jun 20181525171Highwire
Jul 20181924994Highwire
Aug 20181221877Highwire
Sep 20181224472Highwire
Oct 201814283108Highwire
Nov 201822359127Highwire
Dec 2018937972Highwire
Jan 20191025262Highwire
Feb 20192233795Highwire
Mar 201911250129Highwire
Apr 20199356132Highwire
May 20191128995Highwire
Jun 20191532586Highwire
Jul 20191034189Highwire
Aug 201916297108Highwire
Sep 201911317112Highwire
Oct 20191341385Highwire
Nov 20197306102Highwire
Dec 20191126977Highwire
Jan 20201039076Highwire
Feb 20201332792Highwire
Mar 2020927399Highwire
Apr 202010290114Highwire
May 2020532693Highwire
Jun 202015154113Highwire
Jul 2020815298Highwire
Aug 202010251145Highwire
Sep 20205284183Highwire
Oct 202020369117Highwire
Nov 202011283113Highwire
Dec 20201520082Highwire
Jan 20211115695Highwire
Feb 202115173128Highwire
Mar 202114276120Highwire
Apr 202116295124Highwire
May 202114311102Highwire
Jun 202113428100Highwire
Jul 202115271124Highwire
Aug 202111259104Highwire
Sep 2021723071Highwire
Oct 202114266102Highwire
Nov 202111234157Highwire
Dec 20215211101Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me